- SEK9.96bn
- SEK9.24bn
- SEK1.42bn
- 99
- 26
- 31
- 51
Annual balance sheet for Biogaia AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,468 | 1,485 | 1,488 | 1,544 | 1,224 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 143 | 164 | 150 | 140 | 222 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,690 | 1,752 | 1,797 | 1,874 | 1,610 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 163 | 154 | 158 | 213 | 206 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,913 | 2,128 | 2,214 | 2,333 | 2,034 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 135 | 127 | 165 | 196 | 206 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 167 | 251 | 242 | 303 | 310 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1,746 | 1,877 | 1,972 | 2,030 | 1,724 |
| Total Liabilities & Shareholders' Equity | 1,913 | 2,128 | 2,214 | 2,333 | 2,034 |
| Total Common Shares Outstanding |